RxDoctor Payments Data

John Aruny, MD

Vascular & Interventional Radiology · New Haven, CTNPI 1568452969

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 47.1% of the total. Reporting peaked in 2019 at $23,043 and has fallen 98.9% since, to $264 in 2025.

$71,857in general payments, 2019–2025

Across 287 payments — averaging $250.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$34K
  • Boston Scientific$19K
  • Bard Peripheral Vascular, Inc.$6K
  • Venturemed Group, Inc.$5K
  • Medtronic$2K
  • Inari Medical, Inc.$1K
  • plus $4K from 20 others
$105,695in research payments, 2019–2025

Across 22 payments — averaging $4804.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Venturemed Group, Inc.$63K
  • Medtronic$36K
  • Merit Medical Systems Inc$7K

What the payments were for

  • Consulting fees$41,85058%
  • Speaking & faculty fees$6,1008%
  • Travel & lodging$6,99210%
  • Food & beverage$16,91624%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,857 in reported general payments places this provider in the 85th percentile of 50 vascular & interventional radiology providers in Connecticut.

See all vascular & interventional radiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$73,683
Medicare patients
299
Services billed
2,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →